Table 2. Surface electrocardiographic parameters, intracavitary electrograms recordings, and electrophysiological properties of endocardial cells in sham-operated and in pressure-overloaded rats treated with Valsartan or placebo for 12 weeks after surgery.
SHAM (N=10) | SHAM+VAL (N=10) | LVH (N=12) | LVH+VAL (N=10) | |
---|---|---|---|---|
HR, bpm | 437±38 | 434±49 | 399±61 | 392±49 |
RR interval, ms | 138±11 | 140±16 | 155±33 | 155±19 |
PVC, counts/hr | 255±165 | 360±162 | 1200±180* | 650±200# |
QRS duration, ms | 11.2±0.8 | 11.4±1.0 | 15.1±1.3* | 12.0±0.8 |
QRS amplitude, mV | 2.0±0.1 | 2.0±0.2 | 3.2±0.3* | 2.8±0.2# |
Values are expressed as average ± SEM. SHAM, rats undergone left lateral thoracotomy only; SHAM+VAL, rats undergone left lateral thoracotomy and treated with valsartan 10 mg/kg/die; LVH, rats undergone aortic banding; LVH+VAL, rats undergone aortic banding and treated with valsartan 10 mg/kg/die; HR, heart rate; bpm, beats per minute; RR interval, length between two consecutive ventricular depolarizations; PVC, premature ventricular contractions; ms, milliseconds; mV, milliVolts. Analysis of variance has been used in data analysis. *p<0,05 vs. all; #p<0,05 vs. SHAM and SHAM+VAL.